Pfizer India’s shares surged after reporting strong Q3FY26 results, with net profit up 11% and revenue by 20%. The company also recorded exceptional items related to a strategic partnership with Cipla and the impact of new labor laws. The stock shows strong investor sentiment and a bullish technical outlook.